In non-MNA tumours, it has been shown that telomere maintenance is frequently achieved either through (i) genomic rearrangements that place TERT under the control of strong enhancer elements [7] or (ii) ALT, which is associated with ATRX alterations in 55–60% of all ALT-positive cases [8, 9]. This evidence concerns the gene ATRX and neoplasm.